Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire

Author:

Shiroiwa T.ORCID,King M. T.ORCID,Norman R.ORCID,Müller F.ORCID,Campbell R.ORCID,Kemmler G.,Murata T.,Shimozuma K.,Fukuda T.

Abstract

Abstract Purpose This study aimed to develop a Japanese value set for the EORTC QLU-C10D, a multi-attribute utility measure derived from the cancer-specific health-related quality-of-life (HRQL) questionnaire, the EORTC QLQ-C30. The QLU-C10D contains ten HRQL dimensions: physical, role, social and emotional functioning, pain, fatigue, sleep, appetite, nausea, and bowel problems. Methods Quota sampling of a Japanese online panel was used to achieve representativeness of the Japanese general population by sex and age (≥ 18 years). The valuation method was an online discrete choice experiment. Each participant considered 16 choice pairs, randomly assigned from 960 choice pairs. Each pair included two QLU-C10D health states and life expectancy. Data were analyzed using conditional logistic regression, parameterized to fit the quality-adjusted life-year framework. Preference weights were calculated as the ratio of each dimension-level coefficient to the coefficient for life expectancy. Results A total of 2809 eligible panel members consented, 2662/2809 (95%) completed at least one choice pair, and 2435/2662 (91%) completed all choice pairs. Within dimensions, preference weights were generally monotonic. Physical functioning, role functioning, and pain were associated with the largest utility weights. Intermediate utility weights were associated with social functioning and nausea; the remaining symptoms and emotional functioning were associated with smaller utility decrements. The value of the worst health state was − 0.221, lower than that seen in most other existing QLU-C10D country-specific value sets. Conclusions The Japan-specific QLU-C10D value set is suitable for evaluating the cost and utility of oncology treatments for Japanese health technology assessment and decision-making.

Funder

Japanese National Institute of Public Health

National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Reference53 articles.

1. National Institute for Health and Care Excellence. 2013 NICE Process and Methods Guides. Guide to the Methods of Technology Appraisal 2013. London: National Institute for Health and Care Excellence (NICE).

2. Shiroiwa, T. (2020). Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan. International journal of technology assessment in health care, 36(3), 270–276.

3. Center for Outcomes Research and Economic Evaluation for Health. 2022 Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council. Available from https://c2h.niph.go.jp/tools/guideline/guideline_en.pdf. accessed 10 Jan 2023

4. 1990 EuroQol--a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands). 16(3):199–208

5. Shiroiwa, T., Fukuda, T., Ikeda, S., et al. (2016). Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Quality of life Research, 25(3), 707–719.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3